Advanced search
Publication Cover
Emerging Microbes & Infections Volume 13, 2024 - Issue 1
Submit an article Journal homepage
1,642
Views
0
CrossRef citations to date
0
Altmetric
Emerging and Re-Emerging Coronaviruses

Human monoclonal antibody F61 nasal spray effectively protected high-risk populations from SARS-CoV-2 variants during the COVID-19 pandemic from late 2022 to early 2023 in China

Ying Liua Wuhan Jinyintan Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, People’s Republic of China;b Hubei Clinical Research Center for Infectious Diseases, Wuhan, People’s Republic of China;c Hubei Public Health Clinical Center, Wuhan, People’s Republic of China;d Wuhan Research Center for Communicable Disease Diagnosis and Treatment, Wuhan, People’s Republic of ChinaView further author information
,
Jiayou Zhange National Engineering Technology Research Center for Combined Vaccines, Wuhan, People’s Republic of China;f Wuhan Institute of Biological Products Co. Ltd., Wuhan, People’s Republic of ChinaView further author information
,
Wen Liua Wuhan Jinyintan Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, People’s Republic of China;b Hubei Clinical Research Center for Infectious Diseases, Wuhan, People’s Republic of China;c Hubei Public Health Clinical Center, Wuhan, People’s Republic of ChinaView further author information
,
Yongbing Pane National Engineering Technology Research Center for Combined Vaccines, Wuhan, People’s Republic of China;f Wuhan Institute of Biological Products Co. Ltd., Wuhan, People’s Republic of ChinaView further author information
,
Shunan Ruana Wuhan Jinyintan Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, People’s Republic of China;b Hubei Clinical Research Center for Infectious Diseases, Wuhan, People’s Republic of ChinaView further author information
,
Xuanxuan Niane National Engineering Technology Research Center for Combined Vaccines, Wuhan, People’s Republic of China;f Wuhan Institute of Biological Products Co. Ltd., Wuhan, People’s Republic of ChinaView further author information
,
Wei Chene National Engineering Technology Research Center for Combined Vaccines, Wuhan, People’s Republic of China;f Wuhan Institute of Biological Products Co. Ltd., Wuhan, People’s Republic of ChinaView further author information
,
Lina Sung National Institute for Viral Disease Control and Prevention, Chinese CDC, Beijing, People’s Republic of ChinaView further author information
,
Qiangling Ying National Institute for Viral Disease Control and Prevention, Chinese CDC, Beijing, People’s Republic of China;h Hubei Provincial Center for Disease Control and Prevention, Wuhan, People’s Republic of ChinaView further author information
,
Xin Yuee National Engineering Technology Research Center for Combined Vaccines, Wuhan, People’s Republic of China;f Wuhan Institute of Biological Products Co. Ltd., Wuhan, People’s Republic of ChinaView further author information
,
Qingliang Lie National Engineering Technology Research Center for Combined Vaccines, Wuhan, People’s Republic of China;f Wuhan Institute of Biological Products Co. Ltd., Wuhan, People’s Republic of ChinaView further author information
,
Fang Guie National Engineering Technology Research Center for Combined Vaccines, Wuhan, People’s Republic of China;f Wuhan Institute of Biological Products Co. Ltd., Wuhan, People’s Republic of ChinaView further author information
,
Cong Wue National Engineering Technology Research Center for Combined Vaccines, Wuhan, People’s Republic of China;f Wuhan Institute of Biological Products Co. Ltd., Wuhan, People’s Republic of ChinaView further author information
,
Shuzhen Wanga Wuhan Jinyintan Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, People’s Republic of China;b Hubei Clinical Research Center for Infectious Diseases, Wuhan, People’s Republic of ChinaView further author information
,
Yunkai Yangi China National Biotec Group Company Limited,Beijing, People’s Republic of ChinaView further author information
,
Zhaofei Jinge National Engineering Technology Research Center for Combined Vaccines, Wuhan, People’s Republic of China;f Wuhan Institute of Biological Products Co. Ltd., Wuhan, People’s Republic of ChinaView further author information
,
Feiguang Longi China National Biotec Group Company Limited,Beijing, People’s Republic of ChinaView further author information
,
Zejun Wange National Engineering Technology Research Center for Combined Vaccines, Wuhan, People’s Republic of China;f Wuhan Institute of Biological Products Co. Ltd., Wuhan, People’s Republic of ChinaView further author information
,
Zeyu Zhange National Engineering Technology Research Center for Combined Vaccines, Wuhan, People’s Republic of China;f Wuhan Institute of Biological Products Co. Ltd., Wuhan, People’s Republic of ChinaView further author information
,
Chaolin Huanga Wuhan Jinyintan Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, People’s Republic of China;b Hubei Clinical Research Center for Infectious Diseases, Wuhan, People’s Republic of China;c Hubei Public Health Clinical Center, Wuhan, People’s Republic of China;d Wuhan Research Center for Communicable Disease Diagnosis and Treatment, Wuhan, People’s Republic of ChinaCorrespondence[email protected]
View further author information
,
Kai Duane National Engineering Technology Research Center for Combined Vaccines, Wuhan, People’s Republic of China;f Wuhan Institute of Biological Products Co. Ltd., Wuhan, People’s Republic of ChinaCorrespondence[email protected]
View further author information
,
Mifang Liangg National Institute for Viral Disease Control and Prevention, Chinese CDC, Beijing, People’s Republic of ChinaCorrespondence[email protected]
View further author information
&
Xiaoming Yange National Engineering Technology Research Center for Combined Vaccines, Wuhan, People’s Republic of China;f Wuhan Institute of Biological Products Co. Ltd., Wuhan, People’s Republic of China;i China National Biotec Group Company Limited,Beijing, People’s Republic of ChinaCorrespondence[email protected]
View further author information
 show all
Article: 2284297 | Received 27 Aug 2023, Accepted 13 Nov 2023, Published online: 26 Mar 2024

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.